{"id":178481,"date":"2026-07-31T11:03:28","date_gmt":"2026-07-31T05:33:28","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=178481"},"modified":"2026-07-31T11:03:30","modified_gmt":"2026-07-31T05:33:30","slug":"cipla-vs-lupin-comparison","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/cipla-vs-lupin-comparison\/","title":{"rendered":"Cipla vs Lupin: Which Stock Should You Track"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Cipla vs Lupin: a leading Indian pharmaceutical company with respiratory category leadership vs a leading Indian pharmaceutical company in respiratory and cardiovascular generics. Cipla sector: Pha&#8230;<\/em><\/p>\n<p>Cipla vs Lupin is a comparison investors search for because the two companies represent genuinely different positions within Pharmaceuticals. This Cipla vs Lupin breakdown goes beyond generic labels and looks at real numbers: reach, products, the latest results each company has declared, and how each stock is positioned today. Understanding Cipla vs Lupin this way is more useful than a surface-level label, because it shows where each company actually stands rather than how it describes itself.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/cipla-vs-lupin-comparison\/#Cipla_vs_Lupin_Reach_and_Market_Position\" title=\"Cipla vs Lupin: Reach and Market Position\">Cipla vs Lupin: Reach and Market Position<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/cipla-vs-lupin-comparison\/#Cipla_vs_Lupin_Key_Products_and_Business_Mix\" title=\"Cipla vs Lupin: Key Products and Business Mix\">Cipla vs Lupin: Key Products and Business Mix<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/cipla-vs-lupin-comparison\/#Cipla_vs_Lupin_Latest_Results\" title=\"Cipla vs Lupin: Latest Results\">Cipla vs Lupin: Latest Results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/cipla-vs-lupin-comparison\/#Cipla_vs_Lupin_Stock_and_Valuation\" title=\"Cipla vs Lupin: Stock and Valuation\">Cipla vs Lupin: Stock and Valuation<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/cipla-vs-lupin-comparison\/#Cipla_vs_Lupin_Quick_Comparison_Table\" title=\"Cipla vs Lupin: Quick Comparison Table\">Cipla vs Lupin: Quick Comparison Table<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/cipla-vs-lupin-comparison\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/cipla-vs-lupin-comparison\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/cipla-vs-lupin-comparison\/#What_is_the_main_difference_between_Cipla_and_Lupin\" title=\"What is the main difference between Cipla and Lupin?\">What is the main difference between Cipla and Lupin?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/cipla-vs-lupin-comparison\/#How_do_Cipla_and_Lupins_latest_results_compare\" title=\"How do Cipla and Lupin&#8217;s latest results compare?\">How do Cipla and Lupin&#8217;s latest results compare?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/cipla-vs-lupin-comparison\/#What_sector_do_Cipla_and_Lupin_operate_in\" title=\"What sector do Cipla and Lupin operate in?\">What sector do Cipla and Lupin operate in?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/cipla-vs-lupin-comparison\/#Should_I_invest_in_Cipla_or_Lupin\" title=\"Should I invest in Cipla or Lupin?\">Should I invest in Cipla or Lupin?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/cipla-vs-lupin-comparison\/#What_are_the_key_products_of_Cipla\" title=\"What are the key products of Cipla?\">What are the key products of Cipla?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/cipla-vs-lupin-comparison\/#What_are_the_key_products_of_Lupin\" title=\"What are the key products of Lupin?\">What are the key products of Lupin?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/cipla-vs-lupin-comparison\/#How_do_Cipla_and_Lupin_compare_on_market_position\" title=\"How do Cipla and Lupin compare on market position?\">How do Cipla and Lupin compare on market position?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Cipla_vs_Lupin_Reach_and_Market_Position\"><\/span><strong>Cipla vs Lupin: Reach and Market Position<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>In the Cipla vs Lupin comparison, Cipla stands out for a leading Indian pharmaceutical company with a strong respiratory and India-business franchise, maintaining a net cash position of over Rs 9,000 crore. This scale gives Cipla a distinct position within Pharmaceuticals that shapes how it competes.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=cipla-vs-lupin-reach\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<p>Lupin, on the other hand, is built around a Mumbai-based pharmaceutical company with a strong presence in respiratory, cardiovascular and anti-diabetic therapies across India, the US and other global markets. Comparing Cipla vs Lupin on reach alone shows two different growth strategies, not a single verdict.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Cipla_vs_Lupin_Key_Products_and_Business_Mix\"><\/span><strong>Cipla vs Lupin: Key Products and Business Mix<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Cipla&#8217;s business runs on respiratory therapies, generic drugs, oncology treatments, and One India branded formulations. This product mix is central to any Cipla vs Lupin comparison, since it explains where each company&#8217;s revenue actually comes from.<\/p>\n<p>Lupin instead leans on generic and branded formulations across respiratory, cardiovascular, anti-diabetic and anti-infective therapy areas. The Cipla vs Lupin product comparison shows these are genuinely different businesses, not just different brand names in the same category.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Cipla_vs_Lupin_Latest_Results\"><\/span><strong>Cipla vs Lupin: Latest Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Looking at real numbers rather than claims, Cipla&#8217;s latest disclosed results show Q1 FY27 net profit of Rs 785.55 crore, down 39.2% YoY, on revenue of Rs 7,119.28 crore, up 2.33%, with the decline driven by margin contraction and new labour-code-related costs even as India business revenue hit a record Rs 3,452 crore; FY26 revenue was a record Rs 28,000 crore. This is the clearest evidence available for the Cipla vs Lupin comparison on Cipla&#8217;s side.<\/p>\n<p>Lupin&#8217;s latest disclosed results show Positioned by the market among India&#8217;s larger generics exporters, with growth tied to US generic approvals and India branded formulation sales. Weighing Cipla vs Lupin on actual results, rather than headline positioning, is what separates a useful comparison from a generic one.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Compare Cipla and Lupin Fundamentals on the Univest Screener<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Cipla_vs_Lupin_Stock_and_Valuation\"><\/span><strong>Cipla vs Lupin: Stock and Valuation<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>On the market side, Cipla is described as: Maintained a strong net cash position despite the profit decline. Lupin is described as: Tracked alongside Sun Pharma, Dr Reddy&#8217;s, Cipla and Aurobindo Pharma as one of India&#8217;s major listed pharma companies. The Cipla vs Lupin valuation gap often reflects how the market is pricing each company&#8217;s growth and risk profile differently.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Cipla_vs_Lupin_Quick_Comparison_Table\"><\/span><strong>Cipla vs Lupin: Quick Comparison Table<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<tbody>\n<tr>\n<th>Parameter<\/th>\n<th><a href=\"https:\/\/univest.in\/stocks\/cipla\/cipla-ltd-share-price-today\">Cipla<\/a><\/th>\n<th><a href=\"https:\/\/univest.in\/stocks\/lupin\/lupin-ltd-share-price-today\">Lupin<\/a><\/th>\n<\/tr>\n<tr>\n<td>Sector<\/td>\n<td>Pharmaceuticals<\/td>\n<td>Pharmaceuticals<\/td>\n<\/tr>\n<tr>\n<td>Market position<\/td>\n<td>a leading Indian pharmaceutical company with respiratory category leadership<\/td>\n<td>a leading Indian pharmaceutical company in respiratory and cardiovascular generics<\/td>\n<\/tr>\n<tr>\n<td>Reach<\/td>\n<td>a leading Indian pharmaceutical company with a strong respiratory and India-business franc<\/td>\n<td>a Mumbai-based pharmaceutical company with a strong presence in respiratory, cardiovascula<\/td>\n<\/tr>\n<tr>\n<td>Latest results<\/td>\n<td>Q1 FY27 net profit of Rs 785.55 crore, down 39.2% YoY, on revenue of Rs 7,119.28 crore, up 2.33%, wi<\/td>\n<td>Positioned by the market among India&#8217;s larger generics exporters, with growth tied to US generic app<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Cipla vs Lupin ultimately comes down to two companies solving similar problems in different ways. Cipla brings a leading Indian pharmaceutical company with respiratory category leadership, while Lupin brings a leading Indian pharmaceutical company in respiratory and cardiovascular generics. Investors weighing Cipla vs Lupin should track both companies&#8217; upcoming results and valuation gap rather than picking a side on reputation alone. This Cipla vs Lupin breakdown is a starting point, not a final verdict.<\/p>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"https:\/\/apps.apple.com\/in\/app\/univest\/id1543832872\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"https:\/\/play.google.com\/store\/apps\/details?id=com.univest.android\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Cipla and Lupin live price and get daily stock recommendations.<\/em><\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information, including company results filings and exchange data, and are current as of the time of writing. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_main_difference_between_Cipla_and_Lupin\"><\/span><strong>What is the main difference between Cipla and Lupin?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The main difference in the Cipla vs Lupin comparison lies in scale and business mix. Cipla is built on a leading Indian pharmaceutical company with respiratory category leadership, while Lupin is positioned around a leading Indian pharmaceutical company in respiratory and cardiovascular generics.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_do_Cipla_and_Lupins_latest_results_compare\"><\/span><strong>How do Cipla and Lupin&#8217;s latest results compare?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Comparing Cipla vs Lupin on latest disclosed results: Cipla reported Q1 FY27 net profit of Rs 785.55 crore, down 39.2% YoY, on revenue of Rs 7,119.28 crore, up 2.33%, with the decline driven by margin contract, while Lupin reported Positioned by the market among India&#8217;s larger generics exporters, with growth tied to US generic approvals and India branded formulation sal.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_sector_do_Cipla_and_Lupin_operate_in\"><\/span><strong>What sector do Cipla and Lupin operate in?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Cipla operates in Pharmaceuticals and Lupin operates in Pharmaceuticals. Even where the sectors overlap, the Cipla vs Lupin comparison shows different product mixes and market positions.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Should_I_invest_in_Cipla_or_Lupin\"><\/span><strong>Should I invest in Cipla or Lupin?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Both Cipla and Lupin have distinct strengths within their space. Investors comparing Cipla vs Lupin should review the latest quarterly results, valuation and their own risk profile, and consult a financial advisor before deciding.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_products_of_Cipla\"><\/span><strong>What are the key products of Cipla?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Cipla&#8217;s key products and business lines include respiratory therapies, generic drugs, oncology treatments, and One India branded formulations.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_products_of_Lupin\"><\/span><strong>What are the key products of Lupin?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Lupin&#8217;s key products and business lines include generic and branded formulations across respiratory, cardiovascular, anti-diabetic and anti-infective therapy areas.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_do_Cipla_and_Lupin_compare_on_market_position\"><\/span><strong>How do Cipla and Lupin compare on market position?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> On market position, Cipla holds a leading Indian pharmaceutical company with respiratory category leadership, while Lupin holds a leading Indian pharmaceutical company in respiratory and cardiovascular generics. The Cipla vs Lupin comparison shows both companies lead in different ways rather than one being universally ahead.<\/p>\n<div class=\"faq-schema\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Cipla vs Lupin compared on reach, products, latest results and stock performance. See the full data-backed breakdown before you decide.<\/p>\n","protected":false},"author":34,"featured_media":178476,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802],"class_list":["post-178481","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["178476"],"_edit_lock":["1785476014:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["79"],"rank_math_title":["Cipla vs Lupin: Full Stock Comparison"],"rank_math_description":["Cipla vs Lupin compared on reach, products, latest results and stock performance. See the full data-backed breakdown before you decide."],"rank_math_focus_keyword":["Cipla vs Lupin"],"rank_math_robots":["a:2:{i:0;s:8:\"nofollow\";i:1;s:7:\"noindex\";}"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["32350"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/07\/cipla-vs-lupin-comparison.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/178481","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/34"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=178481"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/178481\/revisions"}],"predecessor-version":[{"id":178593,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/178481\/revisions\/178593"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/178476"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=178481"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=178481"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=178481"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}